Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding

- Tzircotis, George, Thorne, Rick F., Isacke, Clare M.

Polymorphisms in a putative enhancer at the 10q21.2 breast cancer risk locus regulate NRBF2 expression

- Darabi, Hatef, McCue, Karen, Dennis, Joe, Cox, A., Cross, S. S., Luben, R., Khaw, K.-T., Choi, J.-Y., Kang, D., Hartman, M., Lim, W. Y., Kabisch, M., Torres, D., Wang, Qin, Jakubowska, A., Lubinski, J., McKay, J., Sangrajrang, S., Toland, A. E., Yannoukakos, D., Shen, C.-Y., Yu, J.-C., Ziogas, A., Schoemaker, M. J., Canisius, Sander, Swerdlow, A., Borresen-Dale, A.-L., Kristensen, V., French, J. D., Edwards, S. L., Dunning, A. M., Easton, D. F., Hall, P., Chenevix-Trench, G., Scott, Christopher G., Apicella, Carmel, Hopper, John L., Southey, Melissa C., Stone, Jennifer, Broeks, Annegien, Schmidt, Marjanka K., Beesley, Jonathan, Scott, Rodney J., Lophatananon, Artitaya, Muir, Kenneth, Beckmann, Matthias W., Ekici, Arif B., Fasching, Peter A., Heusinger, Katharina, dos-Santos-Silva, Isabel, Peto, Julian, Tomlinson, Ian, Michailidou, Kyriaki, Sawyer, Elinor J., Burwinkel, Barbara, Marme, Frederik, Guénel, Pascal, Truong, Thérèse, Bojesen, Stig E., Flyger, Henrik, Benitez, Javier, González-Neira, Anna, Anton-Culver, Hoda, Nord, Silje, Neuhausen, Susan L., Arndt, Volker, Brenner, Hermann, Engel, Christoph, Meindl, Alfons, Schmutzler, Rita K., Arnold, Norbert, Brauch, Hiltrud, Hamann, Ute, Chang-Claude, Jenny, Kar, Siddhartha, Khan, Sofia, Nevanlinna, Heli, Ito, Hidemi, Matsuo, Keitaro, Bogdanova, Natalia V., Dörk, Thilo, Lindblom, Annika, Margolin, Sara, Kosma, Veli-Matti, Mannermaa, Arto, Humphreys, Keith, Tseng, Chiu-chen, Wu, Anna H., Floris, Giuseppe, Lambrechts, Diether, Rudolph, Anja, Peterlongo, Paolo, Radice, Paolo, Couch, F. J., Vachon, C., Giles, G. G., Thompson, Deborah, McLean, C., Milne, R. L., Dugué, P.-A., Haiman, C. A., Maskarinec, G., Woolcott, C., Henderson, B. E., Goldberg, M. S., Simard, J., Teo, S. H., Ghoussaini, Maya, Mariapun, S., Helland, A., Haakensen, V., Zheng, W., Beeghly-Fadiel, A., Tamimi, R., Jukkola-Vuorinen, A., Winqvist, R., Andrulis, I. L., Knight, J. A., Bolla, Manjeet K., Devilee, P., Tollenaar, R. A. E. M., Figueroa, J., García-Closas, M., Czene, K., Hooning, M. J., Tilanus-Linthorst, M., Li, J., Gao, Y.-T., Shu, X.-O.

The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer

- Avery-Kiejda, Kelly A., Braye, Stephen G., Forbes, John F., Scott, Rodney J.

Symptoms of endocrine treatment and outcome in the BIG 1-98 study

- Huober, J., Cole, B. F., Smith, I., Wardley, A., Price, K. N., Goldhirsch, A., Coates, A. S., Colleoni, M., Gelber, R. D., Thürlimann, B., Rabaglio, M., Giobbie-Hurder, A., Wu, J., Ejlertsen, B., Bonnefoi, H., Forbes, J. F., Neven, P., Láng, I.

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

- Ribi, Karin, Luo, Weixiu, Chia, Stephen, Harvey, Vernon J., Giobbie-Hurder, Anita, Fleming, Gini F., Pagani, Olivia, Di Leo, Angelo, Colleoni, Marco, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Walley, Barbara A., Regan, Meredith M., Bernhard, Jürg, Burstein, Harold J., Chirgwin, Jacquie, Ansari, Rafat H., Salim, Muhammed, van der Westhuizen, Andre, Abdi, Ehtesham, Francis, Prudence A.

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

- Milioli, Heloisa H., Tishchenko, Inna, Riveros, Carlos, Berretta, Regina, Moscato, Pablo

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

- Purrington, Kristen S., Visscher, Daniel W., Kotoula, Vassiliki, Fountzilas, George, Kabisch, Maria, Rüdiger, Thomas, Heikkilä, Päivi, Blomqvist, Carl, Cross, Simon S., Southey, Melissa C., Olson, Janet E., Gilbert, Judy, Wang, Chen, Scott, Rodney, Yannoukakos, Drakoulis, Hamann, Ute, Nevanlinna, Heli, Cox, Angela, Giles, Graham G., Eckel-Passow, Jeanette E., Lakis, Sotiris

Reevaluation of RINT1 as a breast cancer predisposition gene

- Li, Na, Thompson, Ella R., Gorringe, Kylie L., James, Paul A., Campbell, Ian G., Rowley, Simone M., McInerny, Simone, Devereux, Lisa, Goode, David, LifePool Investigators,, Wong-Brown, Michelle W., Scott, Rodney J., Trainer, Alison H.

Genetic and epigenetic changes associated with the development of lymph node metastasis in triple negative breast cancer

- Mathe, Andrea

Neurotrophins and their receptors in breast cancer

- Hondermarck, Hubert

The implementation of a decision aid for women with early-stage breast cancer considering contralateral prophylactic mastectomy: A pilot study

- Jansen, J., Serafimovska, A., Glassey, R., Zdenkowski, N., Saunders, C., Porter, D., Butow, P.

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the Breast International Group 1-98 trial

- Ewertz, Marianne, Gray, Kathryn P., Gelber, Richard D., Colleoni, Marco, Láng, István, Smith, Ian E., Coates, Alan S., Goldhirsch, Aron, Mouridsen, Henning T., Regan, Meredith M., Ejlertsen, Bent, Price, Karen N., Thürlimann, Beat, Bonnefoi, Hervé, Forbes, John F., Paridaens, Robert J., Rabaglio, Manuela

Thrombin generation as a predictor of radiotherapy induced skin erythema

- Lincz, Lisa F., Gupta, Sanjiv A., Wratten, Christopher R., Kilmurray, Janice, Nash, Sharon, Seldon, Michael, O'Brien, Peter C., Bell, Katy J. L., Denham, James W.

The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low ∆40p53:p53 ratio and better outcome

- Morten, Brianna C., Wong-Brown, Michelle W., Scott, Rodney J., Avery-Kiejda, Kelly A.

Novel genes associated with lymph node metastasis in triple negative breast cancer

- Mathe, Andrea, Wong-Brown, Michelle, Morten, Brianna, Forbes, John F., Braye, Stephen G., Avery-Kiejda, Kelly A., Scott, Rodney J.

Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression

- Heng, Benjamin, Bilgin, Ayse A., Guillemin, Gilles J., Lovejoy, David B., Tan, Vanessa X., Milioli, Heloisa H., Gluch, Laurence, Bustamante, Sonia, Sabaretnam, Tharani, Moscato, Pablo, Lim, Chai K.

Panel testing for familial breast cancer: calibrating the tension between research and clinical care

- Thompson, Ella R., Rowley, Simone M., Campbell, Ian G., Li, Na, McInerny, Simone, Devereux, Lisa, Wong-Brown, Michelle W., Trainer, Alison H., Mitchell, Gillian, Scott, Rodeny J., James, Paul A.

Strategies to support shared decision making in breast cancer

- Rutherford, Claudia, Zdenkowski, Nicholas

Antagonists of IGF: Vitronectin Interactions Inhibit IGF-I-Induced Breast Cancer Cell Functions

- Kashyap, Abhishek S., Shooter, Gary K., Hollier, Brett G., Shokoohmand, Ali, McGovern, Jacqui, Sivaramakrishnan, Manaswini, Croll, Tristan I., Cane, Gaëlle, Leavesley, David I., Söderberg, Ola, Upton, Zee

Mobile breast cancer e-support program for Chinese women with breast cancer undergoing chemotherapy (Part 1): qualitative study of women's perceptions

- Zhu, Jiemin, Ebert, Lyn, Guo, Dongmei, Yang, Sumei, Han, Qiuying, Chan, Sally Wai-Chi